Drug Trial Radar · NCT07274137
A Phase III Study to Evaluate the Efficacy and Safety of MDR-001 in Adult Participants With Overweight or Obesity (MOBILE)
Last checked: Nov 19, 2026Latest source record: Dec 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
738
Planned (sponsor's estimate)
Start
Feb 2026
Primary completion
Jun 2027
Study completion Jul 2027
Sponsor
- Lead sponsor
- MindRank AI LtdIndustry
- Sponsor type
- Industry
- First posted
- Dec 10, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, double-blind, placebo-controlled, phase III clinical study to evaluate the efficacy and safety of the oral small molecule MDR-001 Tablets over 52 weeks as an adjunct to a lifestyle intervention in participants with overweight or obesity.The goal of this clinical trial is to determine whether the oral drug MDR-001 can improve weight management in adult participants with overweight or obesity.
Conditions
- Overweight or Obesity
Interventions
MDR-001Drug
Participants will Receive Small Molecule MDR-001 Tablets Administered Orally
PlaceboDrug
Participants will Receive Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage change from baseline in body weight (%) at Week 52Time frame: baseline,Week 52
- Percentage (%) of participants who achieve≥5% body weight reduction from baseline at Week 52Time frame: baseline,Week 52
Locations
45 sites in 1 country. Site status is shown where the registry gives one.
Peking University People's Hospital
Beijing, China
The Second Hospital of Jilin University
Changchun, China
The First People's Hospital of Changde City
Changde, China
People's Hospital of Hunan Province
Changsha, China
The Fourth Hospital of Changsha
Changsha, China
The Third People's Hospital of Datong
Datong, China
Dongyang People's Hospital
Dongyang, China
Ganzhou People's Hospital
Ganzhou, China
The Second Hospital of Anhui Medical University
Hefei, China
The SecondPeople's Hospital of Hefei
Hefei, China
Huizhou Central People's Hospital
Huizhou, China
Huizhou Third People's Hospital
Huizhou, China
Huzhou Central Hospital
Huzhou, China
Central Hospital Affiliated To Shangdong First Medical University
Jinan, China
Central Hospital of Jin zhou
Jinzhou, China
Jingzhou Hospital Affiliated to Yangtze University
Jinzhou, China
The Third Affiliated Hospital of Jinzhou Medical University
Jinzhou, China
JiuJiang No.1 people's Hospital
Jiujiang, China
Lianyungang Hospital of TCM
Lianyungang, China
Liaocheng People's Hospital
Liaocheng, China
Loudi Central Hospital
Loudi, China
The First Affiliated Hospital of Ningbo University
Ningbo, China
Pingxiang People's Hospital
Pingxiang, China
Sanya Central Hospital (Hainan Third People's Hospital)
Sanya, China
Shenyang Fifth People Hospital
Shenyang, China
Shenyang Sixth People's Hospital
Shenyang, China
The People's Hospital of liaoning Province
Shenyang, China
The Second Hospital of Hebei Medical University
Shijia Zhuang, China
Siping Central People's Hospital
Siping, China
The First Affiliated Hospital of Soochow University
Suzhou, China
First Hospital of Shanxi Medical University
Taiyuan, China
Shanxi Bethune Hospital
Taiyuan, China
Taizhou Hospital of Zhejiang province
Taizhou, China
Wuhan Third Hospital•Tongren Hospital of Wuhan University
Wuhan, China
Xuancheng People's Hospital
Xuancheng, China
Yichang Central People's Hospital
Yibin, China
Yichang Central People's Hospital
Yichang, China
Yueyang Central Hospital
Yueyang, China
Yueyang People's Hospital
Yueyang, China
The Second Affiliated Hospital of ZhengzhouUniversity
Zhengzhou, China
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.